Literature DB >> 3585741

A new simplified assay for the quantitation of theophylline and its major metabolites in urine by high-performance liquid chromatography.

M B Kester, C L Saccar, M L Rocci, H C Mansmann.   

Abstract

A high-performance liquid chromatographic technique is presented for the simultaneous determination of theophylline, 3-methylxanthine, 1-methyluric acid, 1,3-dimethyluric acid, and caffeine in urine using beta-hydroxyethyl theophylline (BHET) as an internal standard. Following centrifugation of the sample, 2 mL of urine was placed onto a Sep-Pak C18 cartridge (Waters Associates, Milford, MA, USA) that was prepared with 5 mL of methanol followed by 10 mL of distilled water. The compounds were eluted with 2.5 mL of a methanol:water (50:50) mixture. An aliquot of the filtered urine sample (100 microL) was added to 40 microL of an internal standard solution (BHET; 100 micrograms/mL). Distilled water (60 microL) was added to yield a volume of 200 microL. The mixture was vortexed and centrifuged, and 100 microL was injected onto a C8 column maintained at 55 degrees C. Inter- and intraday variability of the assay for all compounds was less than 5.7%. Sensitivity ranged from 0.10 microgram/mL for caffeine to 0.68 microgram/mL for 1-methyluric acid. Drugs commonly coadministered with theophylline did not interfere with the assay.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585741     DOI: 10.1002/jps.2600760312

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Individualization of theophylline infusion rate on the basis of a nonlinear compartmental pharmacokinetic model.

Authors:  G C Nikiforidis; C P Argyropoulos; T I Kassimatis; D S Ithakissios
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.569

2.  Simple, fast and reliable liquid chromatographic and spectrophotometric methods for the determination of theophylline in urine, saliva and plasma samples.

Authors:  Mohammad Charehsaz; Aylin Gürbay; Ahmet Aydin; Gönül Sahin
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.